logo
Select company
Select metric
$ -118.89MShareholders Equity
VS
Market
3
Sector
3
Industry
3
History
-
$ 5.19Close
$ 0.84 - $ 5.94 52-Week Range
Ticker Information

Ticker

GALT

Company Name

GALECTIN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

GALECTIN THERAPEUTICS INC - Shareholders Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GALT - Equity Historical data
DateShareholders Equity
6/30/2025$ -118.89M
3/31/2025$ -113.98M
12/31/2024$ -104.79M
9/30/2024$ -94.2M
6/30/2024$ -83.87M
3/31/2024$ -72.81M
12/31/2023$ -61.96M
9/30/2023$ -52.6M
6/30/2023$ -52.85M
3/31/2023$ -44.37M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Shareholders Equity

[Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.

GALT - Shareholders Equity, Last 5 years

$ -118.89M

Minimum

Jun 30, 2025

$ 29.82M

Maximum

Sep 30, 2020

$ -39.53M

Average

$ -39.14M

Median

Equity Benchmark Analysis

The chart above depicts the distribution of Equity for companies in the Total Stock Market. The average Equity of the companies is $ 384.64M with a standard deviation of $ 549.08M.
The following table provides additional summary stats:
Equity in the Market:
filtered constituents3.47K
min$ -1.4B
max$ 2.14B
average$ 384.64M
median$ 166.2M
std$ 549.08M